Amphastar Pharmaceuticals Inc share price logo

Amphastar Pharmaceuticals Inc Share Price

NASDAQ: AMPH

Mid Cap

$26.92

-0.35

(-1.28%)

as on

Amphastar Pharmaceuticals Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $26.87
    $27.51
    downward going graph

    0.19%

    Downside

    2.19%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $20.39
    $53.96
    downward going graph

    24.28%

    Downside

    100.43%

    Upside

    downward going graph

Amphastar Pharmaceuticals Inc share price movements today

Previous Close
$27.27
Open
$27.51
Volume
421.3K
Day's Low - High
$26.87 - $27.51
52 Week Low - High
$20.39 - $53.96

Amphastar Pharmaceuticals Inc Historical Returns

1 Month Return
-8.58 %
3 Month Return
+ 4.97 %
1 Year Return
-43.63 %
3 Year Return
-6.71 %
5 Year Return
+ 39.92 %

Amphastar Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Amphastar Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

3.3217

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.12%

PE Ratio (TTM)

10.21

Industry PE ratio

10.127857142857144

P/B Ratio

10.2135

PEG Ratio

2.77

EBITDA

236.7M

Revenue (TTM)

722.7M

Profit Margin

18.64%

Return On Equity TTM

18.32%

Amphastar Pharmaceuticals Inc Stock Valuation

Track how Amphastar Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Amphastar Pharmaceuticals Inc in the last 5 years

  • Overview

  • Trends

Lowest (7.15x)

June 30, 2025

Industry (10.13x)

September 16, 2025

Today (10.21x)

September 16, 2025

Highest (36.61x)

September 30, 2020

LowHigh

Today’s Price to Earnings Ratio: 10.21x

Amphastar Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amphastar Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Amphastar Pharmaceuticals Inc image
Amphastar Pharmaceuticals Inc
BUY$1.3B39.92%10.2118.64%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$18.3BNA15.840.36%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$44.1BNA21.813.81%
Neurocrine Biosciences Inc. image
Neurocrine Biosciences Inc.
BUY$14.1B38.75%42.0513.88%
Zoetis Inc. image
Zoetis Inc.
BUY$65.7B-9.3%25.5227.83%

Stock Returns calculator for Amphastar Pharmaceuticals Inc Stock including INR - Dollar returns

The Amphastar Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Amphastar Pharmaceuticals Inc investment value today

Current value as on today

₹60,510

Returns

₹39,490

(-39.49%)

Returns from Amphastar Pharmaceuticals Inc Stock

₹44,357 (-44.36%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Amphastar Pharmaceuticals Inc Stock

Based on 12 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 12 analysts, 75% of analysts recommend a 'BUY' rating for Amphastar Pharmaceuticals Inc. Average target price of $32.67

Amphastar Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Amphastar Pharmaceuticals Inc.

What analysts predicted

17.6%UPSIDE

Target Price

$32.67

Current Price

$26.92

Analyzed by

12 Analysts

Target

$32.67

Amphastar Pharmaceuticals Inc target price $32.67, a slight upside of 17.6% compared to current price of $26.92. According to 12 analysts rating.

Amphastar Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Amphastar Pharmaceuticals Inc Stock has decreased by -72% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-72% versus previous 30 day period

Amphastar Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
140
145
180
178
171
182
188
186
170
174
Gross Profit
73
72
108
93
87
92
101
86
85
86
Operating Income
26
36
72
53
48
55
57
45
37
42
EBITDA
41
43
90
67
61
69
68
65
52
61
Interest Expense
0
3
13
9
8
8
6
6
6
6
Depreciation
7
7
13
13
13
14
14
14
15
16
Income Before Tax
33
32
63
40
47
50
47
43
30
39
Income Tax Expense
6
6
14
4
4
12
7
5
5
8
Net Income
26
26
49
36
43
37
40
37
25
31
Net Profit Margin
18.59%
17.93%
27.26%
20.31%
25.13%
20.81%
21.41%
20.35%
14.83%
17.79%

Amphastar Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
251
255
240
294
322
349
437
498
644
712
Gross Profit
77
104
90
106
131
143
199
248
351
373
Operating Income
-6
15
0
-8
0
10
69
107
196
205
EBITDA
3
30
11
7
21
30
111
146
240
277
Interest Expense
0
1
0
0
0
0
0
1
27
30
Depreciation
-
-
15
16
21
25
26
28
35
57
Income Before Tax
-10
14
1
-9
60
4
84
114
169
189
Income Tax Expense
-7
4
-2
-3
13
3
20
23
31
29
Net Income
-2
10
4
-5
48
1
62
91
137
159
Net Profit Margin
-1.11%
4.13%
1.88%
-1.95%
15.18%
0.40%
14.19%
18.31%
21.34%
22.38%

Amphastar Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
26
49
36
43
37
40
37
25
31
Operating Cash Flow
54
64
23
55
69
59
29
35
35
Investing Cash Flow
-508
-31
-103
15
-69
-34
-35
10
0
Financing Cash Flow
428
86
-47
-13
-10
-22
-33
-14
-30
Change in Cash
-25
119
-126
56
-11
2
-40
31
4

Amphastar Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
10
4
-6
46
1
63
91
137
159
Operating Cash Flow
38
39
38
41
57
97
89
183
213
Investing Cash Flow
-39
-38
-42
-50
-36
-28
-32
-649
-124
Financing Cash Flow
7
-7
25
-3
-2
-37
-26
454
-80
Change in Cash
6
-6
20
-12
18
32
29
-11
7

Global Institutional Holdings in Amphastar Pharmaceuticals Inc

Funds
Holdings
BlackRock Inc
13.22%
Vanguard Group Inc
5.21%
TD Asset Management Inc
4.38%
State Street Corp
3.45%
Dimensional Fund Advisors, Inc.
2.92%
See all

Insights on Amphastar Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 170.52M → 174.41M (in $), with an average increase of 2.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 25.28M → 31.03M (in $), with an average increase of 18.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 84.8% return, outperforming this stock by 91.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 16.8% return, outperforming this stock by 60.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AMPH stock has moved down by -4.0%

About Amphastar Pharmaceuticals Inc

amphastar pharmaceuticals, inc., headquartered in rancho cucamonga, california, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cgmp compliant facilities to develop, manufacture, and market injectable and inhalation products. in addition to the corporate headquarters, amphastar has five manufacturing facilities located in the united states, china and europe along with a state-of-the-art new drug research center. amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. we currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the u.s. enables it to establish significant market share upon the int
OrganisationAmphastar Pharmaceuticals Inc
Headquarters11570 6th Street, Rancho Cucamonga, CA, United States, 91730
IndustryHealth Technology
CEODr. Yongfeng Zhang Ph.D.
E-voting on sharesClick here to vote

Key Management of Amphastar Pharmaceuticals Inc

Name

Title

Dr. Yongfeng Zhang Ph.D.

Co-Founder, President, CEO, Chief Scientific Officer & Director

Mr. William J. Peters M.B.A.

CFO, Executive VP of Finance, Treasurer & Director

Mr. Jacob Liawatidewi M.B.A.

Executive VP of Sales, Marketing & Corporate Administration Center, Corporate Secretary and Director

Mr. Rong Zhou M.S.

Senior EVP of Production & EVP of Scientific Affairs

Mr. Dan Dischner M.B.A.

Senior Vice President of Human Resources & Corporate Communication

Tony Marrs M.B.A., M.P.H., M.S.

Executive VP of Regulatory Affairs & Clinical Operations

Dr. Ziping Luo Ph.D.

Chairman of the Board, Chief Scientist & COO

FAQs

What is Amphastar Pharmaceuticals Inc share price today?

Amphastar Pharmaceuticals Inc share price today is $26.92 as on at the close of the market. Amphastar Pharmaceuticals Inc share today touched a day high of $27.51 and a low of $26.87.

What is the 52 week high and 52 week low for Amphastar Pharmaceuticals Inc share?

Amphastar Pharmaceuticals Inc share touched a 52 week high of $53.96 on and a 52 week low of $20.39 on . Amphastar Pharmaceuticals Inc stock price today i.e. is closed at $26.92,which is 50.11% down from its 52 week high and 32.06% up from its 52 week low.

What is Amphastar Pharmaceuticals Inc's market capitalisation today?

Amphastar Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Amphastar Pharmaceuticals Inc Stock (AMPH) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amphastar Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amphastar Pharmaceuticals Inc Shares that will get you 0.0557 shares as per Amphastar Pharmaceuticals Inc share price of $26.92 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Amphastar Pharmaceuticals Inc Stock (AMPH) from India?

Indian investors can start investing in Amphastar Pharmaceuticals Inc (AMPH) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Amphastar Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Amphastar Pharmaceuticals Inc share’s latest price of $26.92 as on September 17, 2025 at 1:29 am IST, you will get 0.3715 shares of Amphastar Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Amphastar Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Amphastar Pharmaceuticals Inc stock has given 39.92% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?